Internal Medicine 1709 - Internal Medicine Alert - May 15, 2013

Target Audience:

This CME activity is intended for the internist/family physician.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/15/13. Term of approval is for one year from this date with the option of yearly renewal.

Faculty Listing:

Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Associate Editors
Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine
UCLA School of Medicine

Barbara A. Phillips, MD, MSPH
Professor of Medicine
University of Kentucky;
Director, Sleep Disorders Center
Samaritan Hospital
Lexington

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD

Clinical Assistant Professor
University of Florida
Gainesville

Ken Grauer, MD
Professor Emeritus in Family Medicine
College of Medicine
University of Florida

Author
Ellen Jo Baron, PhD, D(ABMM)
Professor Emerita
Stanford University School of Medicine
Director of Medical Affairs
Cepheid, Sunnyvale, CA

Peer reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • New Meaning for the Term'╦ťHacking'
  • Is Chelation Therapy Finally Here to Stay?
  • Fecal Transplants Promising for Clostridium difficile
  • Pharmacology Update: Doxylamine Succinate and Pyridoxine HCl Delayed-Release Tablets (Diclegis┬«)
  • Risks and Benefits of an Extended 10-year Tamoxifen Regimen for Breast Cancer
  • Is There More Pro than Con in Probiotics in Critically Ill Adults?
  • The ASH Position Paper on Orthostatic Hypotension
  • ECG Review: WCT in a Renal Patient

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • identify cost-effective treatment regimens
  • explain the advantages and disadvantages of new disease screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Lilly, Boehringer Ingelheim, Novo Nordisk, Sunovion, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Lilly, Kowa, Novo Nordisk, and Teva.

Associate editors Harold L. Karpman, MD, FACC, FACP, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Associate editor Barbara A. Phillips, MD, MSPH serves on the speakers bureau for PotomaCME.

Author Ellen Jo Baron, PhD, D(ABMM) is a stockholder for Cepheid, and Immunogenetics, is Director of Medical Affairs for Cepheid, and is on the Scientific Advisory Board for OpGen, Immunogenetics, and NanoMR.

Associate editor Louis Kuritzky, MD is an advisor for Endo, Kowa, Pricara, and Takeda.

Associate editor Ken Grauer, MD is the sole proprietor of KG-EKG Press, and publisher of an ECG pocket brain book.

Copyright 2013 AHC Media. All rights reserved.